|
Product Details:
Payment & Shipping Terms:
|
Name: | Venclexta | Cas: | 1257044-40-8 |
---|---|---|---|
Mf: | C45H50ClN7O7S | Purity: | 99% |
Appearance: | White Powder | Package: | 1kg/bag Or 25kgs/drum |
High Light: | Abt-199 Venclexta,1257044-40-8 Venclexta,White Crystalline Venclexta |
Venclexta CAS 1257044-40-8 Abt-199 Venclexta for Chronic Lymphocytic Leukemia Cll Original Powder Abt-199
Product Name | Ready Stock High Purity Venetoclax CAS NO 1257044-40-8 |
CAS | 1257044-40-8 |
Appearance | White crystalline powder |
Molecular formula | C45H50ClN7O7S |
Molecular Weight | 868.44 |
Assay | 98% |
Shelf Life | 24 months when properly stored |
Storage | Keep in a cool, dry, dark location |
Product Name: ABT-199
Synonyms: ABT-199;ABT-199 (GDC-0199);GDC-0199;ABT-199 100MG;2-(1H-Pyrrolo[2,3-b]pyridin-5-yloxy)-4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl)met;ABT-199, Venetoclax;ABT-199 (GDC-0199)Venetoclax;4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]ami;Venclexta
CAS: 1257044-40-8
MF: C45H50ClN7O7S
MW: 868.44
EINECS: 820-130-9
Description:
ABT-199, also known as venetoclax, is a small, oral chemical molecule used for the treatment of chronic lymphocytic leukemia (CLL) associated with a specific chromosomal abnormality. As a second line treatment drug of CLL, ABT-199 take effects through acting as a BH3-mimetic and inhibitor of Bcl-2 (the anti-apoptotic B-cell lymphoma-2protein), further inducing apoptosis of CLL cells but not platelets. It also has the potential for the treatment of ER-positive breast cancer.
Hot products
Benzocaine | CAS:94-09-7 |
Benzocaine hydrochloride | CAS:23239-88-5 |
Tetracaine hydrochloride | CAS:136-47-0 |
Procaine | CAS:59-46-1 |
Tetracaine | CAS:94-24-6 |
Pramoxine Hydrochloride | CAS:637-58-1 |
Procaine HCl | CAS:51-05-8 |
Lidocaine | CAS:137-58-6 |
Dibucaine hydrochloride | CAS:61-12-1 |
Prilocaine | CAS:721-50-6 |
Propitocaine hydrochloride | CAS:1786-81-8 |
Proparacaine hydrochloride | CAS:5875-06-9 |
Lidocaine hydrochloride | CAS:73-78-9 |
Articaine hydrochloride | CAS:23964-57-0 |
Levobupivacaine hydrochloride | CAS:27262-48-2 |
Ropivacaine hydrochloride | CAS:132112-35-7 |
Bupivacaine | CAS:2180-92-9 |
Bupivacaine hydrochloride | CAS:14252-80-3 |
Contact Person: July
Tel: 25838890